Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S L Wills
420 Cost Minimisation of Respiratory Syncitial Virus Prophylaxis With Palivizumab
Pediatric Research
Child Health
Pediatrics
Perinatology
Related publications
Viral Load in Respiratory Syncytial Virus Infected Premature Newborns Under Prophylaxis With Palivizumab
Virology: Research and Reviews
4cps-069 Evaluation of Palivizumab as Prophylaxis Against Respiratory Syncytial Virus Infection
Hospital Admission of High Risk Infants for Respiratory Syncytial Virus Infection: Implications for Palivizumab Prophylaxis
Archives of Disease in Childhood: Fetal and Neonatal Edition
Pediatrics
Gynecology
Perinatology
Obstetrics
Medicine
Child Health
The Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus-Associated Hospitalizations in Infants With Congenital Diaphragmatic Hernia
Pediatrics and Neonatology
Child Health
Pediatrics
Perinatology
Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants
PharmacoEconomics - Open
Health Policy
Pharmacology
Respiratory Syncytial Virus (RSV) Immune Globulin and Palivizumab for Prevention of RSV Infection
American Journal of Health-System Pharmacy
Medicine
Health Policy
Pharmacology
Pharmacy
Erratum To: Respiratory Hospitalizations and Respiratory Syncytial Virus Prophylaxis in Special Populations
European Journal of Pediatrics
Child Health
Pediatrics
Perinatology
Virus Respiratoire Syncitial (VRS): Un Traitement Bientôt?
Forum Médical Suisse ‒ Swiss Medical Forum
Costs and Cost-Minimisation Analysis.
BMJ